2014 Executive Bonus Awards Summary for NewLink Genetics Corporation

Contract Categories: Human Resources › Bonus & Incentive Agreements
Summary

This document outlines the 2014 bonus awards for key executives at NewLink Genetics Corporation, including the Chairman, President, CFO, Clinical and Regulatory Affairs Officer, and VP of Business Development. It details each executive's bonus target as a percentage of their base salary, the percentage of goals achieved, and the total cash bonus awarded. The document also notes that the CFO, whose employment ended in September 2014, received a prorated bonus as per his separation agreement.

Read More Arrow
EX-10.1 2 nlnk-20150106x8kxex101.htm EXHIBIT - 2014 NLNK-20150106-8K-EX10.1
Exhibit 10.1

2014 Bonus Awards
Name and Title
Bonus Target*
Goal Percentage Achieved
Bonus Target Achieved*
2014 Salary
Total Cash Bonus Awarded
Charles J. Link, Jr., M.D.
60
%
150
%
90
%
$573,200
$515,880
Chairman of the Board and Chief
Executive and Scientific Officer
Nicholas N. Vahanian, M.D.
50
%
150
%
75
%
$453,600
$340,200
President and Chief Medical Officer
Gordon H. Link, Jr.
35
%
75
%
26.25
%
$295,200
$77,490
Chief Financial Officer (1)
W. Jay Ramsey, M.D., Ph.D.
35
%
150
%
52.5
%
$312,200
$163,905
Clinical and Regulatory Affairs Officer
Brian Wiley
30
%
150
%
45
%
$262,500
$118,125
Vice President of Business Development
 
 
 
 
 
 
* Bonus Targets listed as percentage of 2014 Base Salary
 
 
 
 
 
 
(1) Mr. Gordon Link's employment was terminated on September 30, 2014. His separation agreement provided that he would be paid a prorated bonus equal to 75% of his target bonus for the year.